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Abstract: Obesity in pregnancy induces metabolic syndrome, low-grade inflammation, altered
endocrine factors, placental function, and the maternal gut microbiome. All these factors impact
fetal growth and development, including brain development. The lipid metabolic transporters of the
maternal-fetal-placental unit are dysregulated in obesity. Consequently, the transport of essential
long-chain PUFAs for fetal brain development is disturbed. The mother’s gut microbiota is vital in
maintaining postnatal energy homeostasis and maternal-fetal immune competence. Obesity during
pregnancy changes the gut microbiota, affecting fetal brain development. Obesity in pregnancy
can induce placental and intrauterine inflammation and thus influence the neurodevelopmental
outcomes of the offspring. Several epidemiological studies observed an association between maternal
obesity and adverse neurodevelopment. This review discusses the effects of maternal obesity and
gut microbiota on fetal neurodevelopment outcomes. In addition, the possible mechanisms of the
impacts of obesity and gut microbiota on fetal brain development are discussed.
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1. Introduction
Obesity during pregnancy is a rising public health concern rapidly increasing worldwide [1–3]. Excessive maternal weight gain during pregnancy is consistently associated
with many adverse impacts, including neurocognitive outcomes in the offspring [1,4].
Recently, the effect of obesity in pregnancy on maternal and fetal health has been reviewed [5,6]. The adverse effect of maternal obesity on the fetal programming of adult
diseases extends beyond non-communicable diseases to brain diseases [7,8]. Obesity and
a high-fat diet predispose offspring to adverse cardiometabolic and neurodevelopmental
outcomes [9]. In addition, maternal high-fat intake during pregnancy was associated with
an elevated risk of neuropsychiatric disorders such as hyperactivity/attention-deficit disorder/anxiety and depressive-like behaviours later in life in offspring [10–18]. Both obesity
and a high-fat diet can impact maternal lipid metabolic state and gut microbial composition
and affect offspring’s metabolic health and brain development [19,20]. Available data
from extensive epidemiologic studies indicate an association between maternal obesity
and adverse neurodevelopmental outcomes in human offspring. Maternal diet, adiposity,
peripheral inflammation, and gut microbiota are the potential mechanisms for underlying
changes in offspring brains and behaviour [20–23].

Nutrients 2022, 14, 4515. https://doi.org/10.3390/nu14214515

https://www.mdpi.com/journal/nutrients

Nutrients 2022, 14, 4515

2 of 16

The diversity of intestinal microbiota during pregnancy has emerged as an essential factor as their metabolites can affect the host’s health in multiple ways, from lipid
metabolism to brain development and function. The microbiota-gut axis can regulate
maternal obesity, diet, lifestyle and physical activity. Gut microbiota produces neurotransmitters and neuromodulators (e.g., serotonin, GABA, SCFAs and their metabolites) and
their derivatives in the circulation. These bioactive factors are transported to the brain via
blood vessels after crossing the BBB and modulate the neonate’s cognitive development
and brain-mediated performance activities. A steady-state microbiota of the mother is
determined by several extrinsic (environment, geography, lifestyle) and intrinsic (genetics,
mode of delivery, eating habits, age, infection, stress, medication) factors. While one-third
of the gut microbial composition is common in most individuals, the remaining two-thirds
are specific to the individual [24]. Despite these, not much data is available on maternal
obesity during pregnancy and the modulation of gut microbial composition and diversity
on the brain development of the offspring.
In this review, we discuss the impacts of maternal obesity and gut microbiota on
offspring brain functionality and development. We also highlight underlying mechanisms
such as maternal metabolic state, maternal and fetal inflammation, placental lipid transport,
maternal gut microbiome, epigenetic modifications of neurotrophic genes, and impaired
serotonergic and dopaminergic signalling.
2. Impacts of Obesity on Maternal Endocrine Factors and Fetal Brain Development
In pregnancy, the maternal metabolism changes dramatically to support fetal growth
and meet maternal additional energy requirements. However, maternal obesity in pregnancy increases maternal complications and enhances the risk of developing obesity, cardiovascular disease, diabetes, and cognitive dysfunction in offspring in adult life [25,26].
Obesity-induced metaflammation results in aberrant changes at the cellular and humoral
levels that contribute to pregnancy complications. However, the physiological inflammatory process favours implantation, placental development, and parturition [27]. Complex
interactions mediate adverse effects of obesity between metabolic, inflammatory, and oxidative stress homeostasis. Obesity in pregnancy is associated with elevated levels of
pro-inflammatory cytokines such as interleukin 6 (IL-6), IL-1β, IL-8, and monocyte chemotactic protein-1 (MCP-1) in both the placenta and in maternal plasma [28,29]. The maternal
obesity-induced swing toward a pro-inflammatory state can affect the neurometabolic state
of the fetus.
Obesity-induced changes in maternal hormone levels can affect gene expression
involved in fetal brain growth and development [30,31]. Obese pregnant women possess
an increased risk of developing thyroid dysfunction during gestation. Maternal hormones
such as thyroid and glucocorticoids affect fetal brain development. The hormones’ effects on
brain development are time- and concentration-dependent [32]. Since obesity is associated
with hypothyroidism and consequently affects brain development [33]. Maternal thyroid
metabolism is also disturbed by maternal iodine deficiency, environmental endocrine
modifiers, and other intrinsic factors associated with thyroid diseases [34].
In early pregnancy, thyroid hormones are needed for brain developmental processes
such as neuronal migration, differentiation of neurons, glial cells, neurogenesis, and synaptogenesis [35,36]. Thyroid hormones regulate gene expression in the cell cycle and intracellular signalling, cytoskeleton organization, extracellular matrix proteins and several
cellular adhesion factors involved in neuronal migration and neurogenesis [35,37]. In addition, thyroid hormones are also involved in neuronal migration and neuron development
by regulating reelin and neurogenin 2 genes [37]. Therefore, optimum maternal thyroid
function is critically required for fetal neurodevelopment.
The altered thyroid hormone levels result in severe neurological deficiency and mental
disability [38]. In addition, thyroid deficiency during pregnancy may drive offspring to
the later onset of neurodevelopmental disorders [34,39,40]. Several neurodevelopmental
deficits are observed in offspring born from mothers with thyroid dysfunction during the

Nutrients 2022, 14, 4515

3 of 16

first half of gestation [41,42]. Even babies of the mother with asymptomatic thyroid dysfunction are at increased risk of impaired brain development [43]. The adverse subclinical
hypothyroidism on fetal neurocognitive development is less specific. Maternal hypothyroxinemia occurs in mild iodine deficiency and may result in neurodevelopmental problems.
Corticosteroids in late gestation are indispensable for fetal brain maturation [44]. The
developing brain is susceptible to corticosteroid-induced stress [45]. A study showed that
prenatal maternal stress increased glucocorticoids, and a high-fat diet, increased the risk
of developing obesity in offspring in later life [46]. Chronic activation of glucocorticoid
receptors alters the levels of glucocorticoid in hippocampal and hypothalamic regions,
thus modifying feedback regulation of the hypothalamic-pituitary-adrenal (HPA) axis [47].
Corticosteroid effects are also mediated via epigenetic changes in genes associated with
synaptic plasticity [48].
Stress hormones such as catecholamines, vasopressin, and oxytocin affect fetal brain
development and functionalities [49]. Chronically increased cortisol levels in maternal
stress result in lower levels of maternal T4 available for the fetal brain, thus affecting fetal
brain development [50].
In addition to thyroid and glucocorticoid, several other hormones play roles in fetal neurodevelopment [51]. Maternal obesity and abnormal hormone levels affect fetal
programming beyond the endocrine and cardiovascular systems to the brain. Several studies showed an association between high maternal BMI and adverse neurodevelopmental
functions in their progenies (Table 1).
Table 1. Epidemiological studies on maternal obesity and neurodevelopment of the offspring.
Observations

References

Increased odds of developing autism spectrum disorders in offspring of obese.

[52–55]

Increases odds of cognitive deficits in children of obese women observed in cohorts.

[55–60]

Obese mothers have twice as likely to have a child with mental developmental delay.

[58,61]

An increase in autism in children was reported in prospective pregnancy cohorts
The maternal obesity was associated with schizophrenia in adult offspring in a large
retrospective cohort study but other studies could not confirm this association.
A dose-dependent increase in relative risk of cerebral palsy as maternal BMI was observed.

[62]
[63,64]
[13,65–67]

3. The Placenta of an Obese Mother and Its Impact on Fetal Brain Development
An increase in total lipid content characterizes the placentas of obese women at term,
infiltrated neutrophils, foam-loaded macrophages and increased levels of pro-inflammatory
mediators [68,69]. The maternal obesity induced-metabolic changes affect early placental
growth, gene expression, and subsequent placental structure and function, which becomes
clinically manifest in late pregnancy [70]. Placental dysfunctions may adversely affect
fetal development [71]. In early pregnancy, the human placenta also responds to elevated
maternal insulin in obese women. Obesity in pregnancy affects human placental structure
and function in many ways. The cellular signalling system may mediate these effects by
modulating inflammation, metabolism, and oxidative stress pathways. These placental
alterations affect pregnancy outcomes independently and synergistically with other risk
factors [6,72]. The placenta is enriched with a complex vascularization for fetal blood
supply that requires extensive angiogenesis. Sub-optimal angiogenesis leads to abnormal
placental size and vasculature. Dysregulated angiogenesis in the placenta may directly
or indirectly involve pregnancies, including pre-eclampsia, pre-term birth [73], GDM [74],
and IUGR [75]. The n-3 fatty acids deficiency reduced the placental transfer of fatty acids
in pre-eclampsia and GDM -associated fetuses [76]. Abnormal placental vasculature is
present in several pathological conditions, such as pre-term birth, intrauterine growth
restriction (IUGR), and pre-eclampsia. Suboptimal placental angiogenesis is contributed
by genetics, dietary and lifestyle factors [77]. Optimal placentation is facilitated by several
angiogenic factors such as vascular endothelial growth factor A (VEGFA), angiopoietin-like
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4 (ANGPTL4), fibroblast growth factor (FGF), and placental growth factor (PlGF), as well
as docosahexaenoic acid, 22:6 n-3 (DHA) [78,79].
High-fat diets and maternal obesity alter the metabolome and early changes in the
placental transcriptome and decrease placenta vascularity [80]. During pregnancy, a maternal high-fat diet promotes ectopic lipid deposition, leading to lipotoxicity and chronic
inflammation in the placenta [81]. Further, the high-fat diet enforces the placenta to adapt
its metabolic response and structural change (thickness) by altering angiogenesis. Animal
studies showed reduced placental labyrinth depth and elevated expression of insulin-like
growth factor 2 (IGF2) and its receptor genes in the fetuses of high-fat diet dams [82]. The
n-3 polyunsaturated fatty acids (n-3 PUFA) deficiency resembles high-fat diet-induced
impaired placental phenotypes. The maternal n-3 PUFA deficiency affected the vascular
development of decidua; the feto-placental unit suggests impacts of maternal fatty acid
status on placental vascularity [83].
The lipid accumulation in the obese placenta results from altered activities of fatty
acid transporter expression, lipoprotein lipase, and alterations to mitochondrial oxidative
metabolism [84,85]. A recent analysis of the genome-wide transcriptome, epigenetics,
and proteomics showed the effects of maternal obesity on placental lipid transport and
metabolism [86,87]. Altered lipid transport and metabolism of the obese placenta, as
reflected by the changes in fatty acid transporters expression, had adverse effects on
smooth placental functioning in transport and the metabolism of lipids across the fetoplacental unit [88–90]. The obese placenta had high total lipids, triglycerides, free fatty
acids, and cholesterol levels. Obese placental phenotype favours excess lipid storage with
reduced lipid transport to the developing fetus, including long-chain polyunsaturated fatty
acids (LCPUFAs) essentially required for fetal brain development [85]. Optimal PUFA is
critical for feto-placental development, and any changes, as in obesity, can have adverse
effects on fetal brain development [91,92].
The pro-inflammatory cascade is favoured by an increased ratio of pro-inflammatory
M1 over anti-inflammatory M2 macrophages during maternal obesity. In addition, obesity
may further enhance pathological pregnancies, such as pre-eclampsia, by reducing the
uterine natural killer (uNK) cell populations [93]. Furthermore, maternal obesity was
associated with epigenetic dysregulations in leptin and adiponectin secretions [94]. Thus,
dysregulated endocrine controls in the term placenta deprive protective effects of these
adipokines on placental development, indicating the placenta’s adaptation to a harmful
maternal environment. Maternal obesity and gestational diabetes mellitus (GDM) also
affect fatty acid transport across the placenta. Increased placental fatty acid binding
protein 4 (FABP4) and endothelial lipase expression were observed in obese women with
diabetes [95,96]. In contrast, reduced levels of FABP5 and lowered uptake of n-6 LCPUFAs
were reported in obese placentas [68,87,97]. Both low and high expressions of fatty acid
translocase CD36/FAT were observed in the placenta of obese women [90,97].
Inflammation and metabolic dysfunction, as observed in obesity, increase placental oxidative, endoplasmic reticulum stress and downstream activation of the placental unfolded
protein response, all of which have been associated with pregnancy complications, such as
fetal growth restriction, pre-eclampsia, and gestational diabetes. Amounts of estradiol and
progesterone concentrations in plasma and placenta are reduced in obese women than in
lean women [98]. The obese placenta is exposed to high insulin in early pregnancy, which
produces altered steroid hormones in mitochondria and affects energy metabolism.
Maternal lipid transport and metabolism regulate fetal adiposity via placental function.
The placental transport of maternal lipids is compromised during pathological states such
as IUGR and GDM. The inefficient placental LCPUFAs transfers and fat-soluble vitamins
may induce metabolic dysfunction and decreased fetal growth. In GDM, the interplay of
the placental ANGPTL4-lipoprotein lipase is responsible for fetal adiposity [99].
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4. Maternal Lipid Transport and Metabolism and Fetal Brain Development
The brain comprises PUFAs, especially long-chain PUFA, in which DHA and ARA
constitute a major fraction of LCPUFAs. DHA levels are relatively higher in the neuronal
membrane (15–50% of total fatty acids) than ARA (2–5%). Neuronal membrane fluidity
facilitates neurotransmitters and synaptic membrane receptors to communicate and transmit signals among the nerve cells [100]. DHA is involved in multiple neurodevelopmental
events, including neuronal differentiation [101], neuritogenesis [102], synaptogenesis [103],
neurite outgrowth [104], synthesis of neuroprotective metabolites [105]. In obese pregnancy,
the n-3 PUFA deficiency state may influence the endogenous synthesis of LCPUFAs from
their precursors. The endogenous production of DHA and ARA is critically essential as
these two fatty acids constitute major fractions of n-3 and n-6 LCPUFA for the brain and
body development of the offspring. [106,107]. Placental delivery of DPA increased in mice
at the expense of decreased DHA transfer during n-3 PUFA deficiency. [83]. Moreover, low
n-3 PUFA-fed mice promoted FATP mRNA expression in the low placenta.
Maternal obesity is correlated with higher birth weight and is usually associated with
n-3 fatty acid deficiency [108]. In utero n-3 PUFA deficiency programs the fetal brain growth
and maturation and reduces neuronal and behavioural plasticity in adulthood [109]. The
DHA is the brain’s predominant structural component, critically required for membrane
fluidity, receptor function, and neuronal signalling [110]. As the brain depends on the DHA
supply by the mother, therefore, deficiency of DHA (as happens in obesity or a high-fat
diet) during brain development in the third trimester possibly affects the maturation and
plasticity of the brain and its performing functions during adult life [110,111]. Arachidonic
acid,20:4n-6 (ARA), quantitatively next to DHA, is required for the rapidly growing brain.
Dietary n-3 fatty acid deficiency reduces DHA-regulated PLA2 and calcium-independent
iPLA2 while upregulating the ARA-selective calcium-dependent cytosolic cPLA2 and
secretory sPLA2 in the frontal cortex of rodents [112].
In addition, the deficiency of n-3 PUFA increases the expression of TNF-a and lowers glutamate receptors in the central nervous system [113]. Moreover, decreased DHA,
n-6 DPA concentration and reduced telencephalon structure were observed in n-3 PUFAdepleted mice hippocampus [114]. Brain performance, such as learning, motor skills, and
monoamine transmission, were affected during n-3 PUFA deficiency [115]. Maternal DHA
deficiency may result in gender-specific offspring’s brain development since the efficiency
of endogenous DHA conversion enzymes differs in males and females. Maternal DHA
deficiency affects the offspring’s stress response, anxiety, [116] and brain reward activities [117]. The deficiency induces hypomyelination in the developing brain, predisposing
the offspring to acquire anxiety-related disorders [116–118].
The free fatty acids uptake of maternal plasma is mediated by intracellular and transmembrane proteins such as FAT/CD36, FATPs, FABPpm, and FABPs in placental trophoblasts [85,119]. Dysregulated placental fatty acid transport carries increased risks of
impaired neurodevelopment [120] and cardiometabolic risks [121] in the offspring. In
addition, offspring born to gestational diabetic mothers reflected reduced DHA in their
cord blood and showed altered rhythmic sleep maturation [122].
DHA-fed rats showed increased BDNF, GluR2, NR2B, and TrkB expression in rat
brains might promote enhanced memory in rats [109,123]. Collectively, evidence suggests
DHA stimulates gene expression directly or by modulating transcription factors of several
membrane-associated mediators in brains that may regulate learning and memory functions. In addition, the deficiency of n-3 PUFA resulted in altered dopamine transmission in
the brain, probably deranged neurogenesis [124]. However, more work is required to relate
maternal obesity and omega-3 deficient conditions in pregnancy and their impact on fetal
brain development. Figure 1 shows the effects of adipose lipids and metabolic hormones in
pregnancies complicated by obesity on fetal brain structure and function.
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Figure 1. Diverse adipokines, cytokines, FABP4 and metabolic stress in obese women may affect fetal
brain development.
In 1.
pregnancies
complicated
by obesity,
these
factors
mediate
crosstalk
among
Figure
Diverse adipokines,
cytokines,
FABP4
and
metabolic
stress
in obese
women may af
fetal brainwithin
development.
In pregnancies
complicated
byregulate
obesity,their
thesefunction.
factors mediate
cross
different cell populations
adipose and
travel to remote
organs to
The
among different cell populations within adipose and travel to remote organs to regulate their fu
long-term neurodevelopmental
programming
is linkedprogramming
to inflammation
and to
placental
serotonin
tion. The long-term
neurodevelopmental
is linked
inflammation
and placental
production and otonin
LCPUFAs
supply. and
Red LCPUFAs
arrows indicate
“upregulation”
while black
arrows indicate
production
supply.
Red arrows indicate
“upregulation”
while black arr
indicate “downregulation
“downregulation”.
5. Maternal
Gut and
Microbiome
and Their
Impacts
onDevelopment
Fetal Brain Development
5. Maternal Gut
Microbiome
Their Impacts
on Fetal
Brain

develop in a sterile microenvironment, as evidenced by a distinct b
Fetuses do notFetuses
developdo
innot
a sterile
microenvironment, as evidenced by a distinct bacteterial signature in the placenta. The placental microbiome of obese pre-pregnant wom
rial signature in
the
placenta.
The
placental
microbiome of obese pre-pregnant women has
has lesser abundance and diversity than women of normal pre-pregnancy weight. T
lesser abundance
and
diversity
than
women
normal
pre-pregnancy
The micromicrobial richness also reducesofwithin
the
placenta fromweight.
the maternal
to the fetal s
bial richness also
reduces
within
the
placenta
from
the
maternal
to
the
fetal
side
[125].ofThe
[125]. The 16SrRNA sequencing of gut, oral and placental microbiomes
the same pr
nant women
suggested
the placental
microbiome
a closer
similarity
with the pr
16SrRNA sequencing
of gut,
oral and that
placental
microbiomes
of the has
same
pregnant
women
nant
oral
microbiome
after
cross-examining
the
oral
non-pregnant
microbiome.
suggested that the placental microbiome has a closer similarity with the pregnant oral The stu
showed that the placental microbiome was enriched by several pathways, including fa
microbiome after
cross-examining the oral non-pregnant microbiome. The study showed
acid metabolism [126]. The oral microflora remained stable during pregnancy but exh
that the placental
microbiome was enriched by several pathways, including fatty-acid
ited distinct composition or abundance compared to the non-pregnant state. Recent e
metabolism [126].
oral microflora
remained
during
pregnancy
but exhibited
denceThe
suggests
that oral-to-gut
and stable
gut-to-oral
microbial
transmission
can regulate
distinct composition
or abundance
compared
topresence
the non-pregnant
state.microbiome
Recent evidence
ease pathogenesis,
confirming
the
of the oral-gut
axis [127]. Mor
ver, oral microflora
during
pregnancy
is modulated
by pathological
states, includ
suggests that oral-to-gut
and gut-to-oral
microbial
transmission
can regulate
disease pathoGDM and
However,
theoral-gut
changesmicrobiome
in oral microbiota
during
pregnancy,
its associat
genesis, confirming
the PE.
presence
of the
axis [127].
Moreover,
oral
with maternal health and its implications for birth outcomes are yet to be reported [12
microflora during pregnancy is modulated by pathological states, including GDM and PE.
The microbiome is an essential functional modulator of the brain and behavi
However, the changes
in oral microbiota during pregnancy, its association with maternal
[129]. Microbial colonization of the GI tract starts early in birth and matures towards ad
health and its implications
forthree
birthyears,
outcomes
areparallel
yet to be
reported
[128].
composition in
closely
with
brain development.
Lifestyle factors
The microbiome is an essential functional modulator of the brain and behaviour [129].
Microbial colonization of the GI tract starts early in birth and matures towards adult composition in three years, closely parallel with brain development. Lifestyle factors like mode
of delivery (vaginal or cesarean) or microbial contamination determine the basal composition of gut microbiota in the neonate. Early postnatal life is a critical determinant for
continued brain development, where infants may have altered gut microbiota depending
on antibiotic use, breastfeeding or formula feeding. Two major experimental approaches,
antibiotic-induced dysbiosis or germ-free animals, established the gut-brain axis’s relationship. Germ-free mice studies highlighted the key role of the gut microbiota in early
brain development [130,131]. The impact of maternal gut microbiota on embryonic development highlighted its role in shaping the neurometabolic system of the offspring. During
pregnancy, maternal microbiota produced short-chain fatty acids (SCFAs) such as butyric
acid, propionic acid, and acetic acid that determine the neuronal, intestinal and pancreatic
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differentiation via embryonic sensing mediated by G protein-coupled receptors, GPR43
and GPR41 [132]. A region-specific change in neurotransmitter systems was noted in the
brains of germ-free mice. Germ-free mice have markedly increased 5-HT concentrations in
the hippocampus [133]. The germ-free mice had upregulated genes involved with brain
plasticity and metabolism, including long-term synaptic potentiation and cyclic adenosine
5-phosphate-mediated signalling system [134]. The microbiome modulates the serotonergic system in early life. A decreased hippocampal expression of the 5-HT1A receptor
gene in the dentate gyrus of female germ-free animals was reported [135]. Brain-derived
neurotrophic factor (BDNF) is an essential plasticity-modulator protein that promotes
neuronal development, growth, and survival and contributes to memory, learning, and
behaviour. Expression of the BDNF gene was reduced in the cortex and amygdala in
germ-free mice [134]. However, the expression of BDNF levels in the hippocampus was
inconsistent in germ-free mice [133,135]. Germ-free animal data showed that the microbiome also regulates post-natal neurogenesis [136]. However, post-weaning microbial
colonization of germ-free mice could not reverse the changes in adult hippocampal neurogenesis. This suggests a vital window exists in the pre-weaning period during which the
microbiota regulates hippocampal neurogenesis [136]. The administration of antibiotics
depleted the microbiota with decreased neurogenesis in adult animals. The antibiotic effect
was reversed by physical activity or consumption of a probiotic cocktail [136]. The use
of antibiotics is negatively associated with the expression of hippocampal BDNF, and the
recognition memory of mice as antibiotic use decreased the gut microbial diversity and
population in infants [137]. The cognitive deficit was associated with reduced bacteriaderived metabolites in the colon, altered lipid composition and changing the expression of
neuronal signalling receptors such as NMDA 2B, tight junction protein, etc.
The gut microbiome does not only affect brain development per se but also alters
hippocampus and amygdala function as well. The amygdala is a critical brain region, a
key node for gating anxiety, fear-related response and social behaviour [138]. Germ-free
(GF) mice brain shows increased amygdala volume and dendritic hypertrophy in the
basolateral amygdala (BLA). The structural and functional alterations of the amygdala are
associated with neuropsychiatric and developmental disorders ranging from anxiety [139]
to autism spectrum disorder [140]. Moreover, germ-free mice have pyramidal BLA neurons,
characterized by stubby, thin, and mushroom spines that mice with normal microbiota [139].
The differentially expressed genes, exon utilization and RNA edits were found in the
amygdala of GF mice. The expression of immediate early response genes such as Fosb, Fos,
and Egr2 was increased in the GF of the amygdala with concomitant increased signalling
of the transcription factor CREB [141]. In germ-free mice, a significant downregulation of
genes related to the immune system was reported [141]. This reflects the underdeveloped
immune system and immature microglia [142]. The immune system plays a key role in
mediating the microbiota’s effects on brain function.
The gut microbiome also critically regulates the pre-frontal cortical myelination [143].
GF mice had hypermyelination and upregulated expression of genes involved in myelination and myelin plasticity events in the pre-frontal cortex [143]. Administration of
antibiotics during early development in rats did not affect cognitive function, immune or
stress-related responses, or anxiety but observed visceral hypersensitivity in their later
life [144]. The latter was associated with changes in the spinal expression of pain-associated
genes [144]. The post-weaning depletion of the gut microbiota by antibiotics showed a relative change in anxiety and cognitive deficits, as observed in GF mice [145]. Moreover, the
depletion reduced anxiety, induced cognitive deficits, changed tryptophan metabolic dynamics, and decreased BDNF, vasopressin, and oxytocin expression in the adult brain [145].
The gut microbiota impacts obesity as the specific microbes can induce excessive
energy extraction and storage from ingested nutrients [146–148]. In addition, gut microbiota
modulates host lipid metabolism [147], and immunity [149], and thus may promote an
aberrant and chronic low-grade inflammation, as observed in obesity [148].
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The gestational microbiome regulates fetal growth, which may impact brain function
and adult mental cognition. Indeed, the gut microbiome is involved in mediating adverse
effects of maternal challenges, such as high-fat diet exposure, obesity [150], immune
activation [151], and psychosocial stress [152,153] on neurobehavioral abnormalities in
mice. In addition, the latest studies indicated that the maternal microbiome modulates host
responses to acute insults in the brain, but it is not known whether it impacts offspring
brain development.
The maternal gut microbiome promotes fetal thalamocortical axonogenesis by signalling microbe-modulating metabolites to develop neurons in the brain [20]. “Dysbiosis”
of the maternal gut microbiome, in response to a high-fat diet [150], stress [153], and infection [151] during pregnancy, is associated with abnormal brain function and behaviour
in the offspring [129]. Manipulating the maternal microbiome and its metabolites during
pregnancy produce offspring with altered tactile sensitivity in two aversive somatosensory
behavioural tasks, with no overt differences in many other sensorimotor behaviours. The
gut microbiota modulates numerous bioactive compounds in the intestine, blood and various other organs [154]. The maternal gut microbiota regulates metabolites in the maternal
and fetal tissues, including the fetal brain. The maternal gut microbiota-regulated fetal
brain metabolites can modulate axon outgrowth in thalamic explants of mice and promote
fetal thalamocortical axonogenesis in offspring. Microbiome metabolites trimethylamineN-oxide, imidazole propionate, N, N, N-trimethyl-5-aminovalerate, 3-indoxyl sulfate and
hippurate are involved with neurological status and neurite outgrowth [20], although the
molecular mechanisms of actions of these microbial metabolites are still not known. A
poorly developed maternal microbiome was associated with decreased brain white matter
in the adult offspring [20,155–157]. Inflammation-induced changes in the maternal gut
microbiome disrupted somatosensory cortical architecture in adult mouse offspring [158].
The microbiomes in malnourished children showed dysregulated expression of axonogenesis proteins, which were alleviated by treatment with microbiota-enriched diets [159].
Epidemiological data also associated maternal infection and antibiotic use with a greater
risk for neurodevelopmental complications in the offspring [19,160]. Whether alterations
may mediate these effects in the maternal microbiome of human remain unclear. The interactions between the gut microbiome and fetal nervous system begin prenatally through
influences of the maternal gut microbiota on fetal brain metabolomic profiles and gene
expression. However, new studies are required to identify whether early to mid-gestation is
a critical period during which the maternal microbiome promotes fetal neurodevelopment
to support developmental processes. Figure 2 describes the maternal microbiota in obesity
exerts effects on the neonatal brain and development.
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